Ultime notizie per Humble Gr (OTC:HMBAF) Azioni

Humble Group AB is a Swedish foodtech and FMCG group. Humble targets the foodtech, eco, sustainability and vegan segments to drive organic growth and acquisitions in the various business units: brands, distribution, manufacturing and ingredients, and R&D. Its technical solutions facilitate new formulations and recipes that improve the taste and consistency of the next generation of sugar-reduced, sustainable, and vegan products.

Humble Group AB

Heritage Commerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTBK#NASDAQ">HTBK</a>) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.19 by 10.53 percent. This is a 40 percent increase over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $47.782 million which beat the analyst consensus estimate of $45.282 million by 5.52 percent. This is a 14.50 percent increase over sales of $41.731 million the same period last year.

Earnings

Earnings Beats

News

HTBK

CORRECTION: Heritage Commerce Q2 Adj. EPS $0.21 Beats $0.19 Estimate, Sales $47.782M Beat $45.282M Estimate

<a href="https://variety.com/2025/tv/news/fcc-approves-paramount-skydance-merger-deal-conditions-1236459974/">https://variety.com/2025/tv/news/fcc-approves-paramount-skydance-merger-deal-conditions-1236459974/</a>

General

PARA

'FCC Approves Paramount-Skydance Deal After Skydance's CBS Ombudsman, Anti-DEI Pledges'- Variety

SB Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFG#NASDAQ">SBFG</a>) reported quarterly earnings of $0.58 per share which beat the analyst consensus estimate of $0.54 by 7.41 percent. This is a 26.09 percent increase over earnings of $0.46 per share from the same period last year. The company reported quarterly sales of $17.176 million which beat the analyst consensus estimate of $13.760 million by 24.83 percent. This is a 22.29 percent increase over sales of $14.045 million the same period last year.

SBFG

CORRECTION: SB Finl Gr Q2 Adj. EPS $0.58 Beats $0.54 Estimate, Sales $17.176M Beat $13.760M Estimate

Deutsche Boerse (OTC:<a class="ticker" href="https://www.benzinga.com/stock/DBOEY#OTC">DBOEY</a>) reported quarterly earnings of $0.34 per share. This is a 9.68 percent increase over earnings of $0.31 per share from the same period last year. The company reported $1.706 billion in sales this quarter. This is a 9.45 percent decrease over sales of $1.884 billion the same period last year.

DBOEY

Deutsche Boerse Q2 Adj. EPS $0.34 Up From $0.31 YoY, Sales $1.706B Down From $1.884B YoY

GREENFIELD, Ind., July 24, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELAN#NYSE">ELAN</a>) announced today that Zenrelia&#x2122; (ilunocitinib) has received approval by the European Commission.
&nbsp;
This approval by the EU reinforces Zenrelia's status as a highly effective, convenient, and safe once-daily oral JAK inhibitor. Zenrelia's approval represents a significant milestone in the EU canine dermatology market, offering a once-daily tablet solution for control pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.
"Our EU approval for Zenrelia is a pivotal achievement, making it our most rapidly expanding product and solidifying our position as a leader in pet health innovation," stated Dr. Ellen de Brabander, Executive Vice President of Innovation and Regulatory Affairs at Elanco. "We've seen remarkable results from our rigorous head-to-head study against the market leader and in real-world settings where Zenrelia is already approved and being used. We're excited to provide veterinarians across the EU with this impactful solution, offering relief to countless dogs suffering from itchy and inflamed skin."
Elanco is pleased the label is consistent with other markets outside North America where the product has already been approved. Zenrelia is available in Brazil, Canada, Japan and the United States, and the company expects additional approvals in key geographies.
"We're excited to bring Zenrelia to veterinarians and pet owners in Europe and provide a new solution to bring relief to itchy dogs, while changing the standard of care to a single daily dose," said Ramiro Cabral, Executive Vice President, Elanco International. "Our commercial teams are ready and product launch will begin immediately, with supply availability expected in the third quarter. Zenrelia joins our growing pet health portfolio in Europe, including AdTab, Credelio, Galliprant and others."
As part of the EU approval process, Elanco conducted a head-to-head non-inferiority study versus the marketplace incumbent, Apoquel. The randomized, double-blind study of 338 client-owned dogs with confirmed atopic dermatitis was conducted across 25 study sites in four countries. The study shows one daily dose of Zenrelia is at least as effective as the market incumbent JAK inhibitor at the primary end point on Day 28. The study is published in a leading peer-reviewed, international journal, Veterinary Dermatology: <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4475126-1&amp;h=653960695&amp;u=https%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1111%2Fvde.13319&amp;a=https%3A%2F%2Fdoi.org%2F10.1111%2Fvde.13319.">https://doi.org/10.1111/vde.13319.</a>
Details on the marketing authorization will be shared on the European Commission website in the coming days.
ABOUT ELANCO

ELAN

Elanco Animal Health Receives Approval From The European Commission For Zenrelia; Zenrelia To Launch Immediately In Market By Q3 2025

MRBK

Meridian Q2 EPS $0.49 Beats $0.42 Estimate, Sales $32.447M Beat $29.782M Estimate

Ikena Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IKNA#NASDAQ">IKNA</a>) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.14) by 57.14 percent. This is a 78.57 percent increase over losses of $(0.28) per share from the same period last year.

IKNA

Ikena Oncology Q2 EPS $(0.06) Beats $(0.14) Estimate

Mr. Cooper Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COOP#NASDAQ">COOP</a>) has outperformed the market over the past 5 years by 47.38% on an annualized basis producing an average annual return of 61.97%. Currently, Mr. Cooper Gr has a market capitalization of $10.01 billion. 
Buying $100 In COOP: If an investor had bought $100 of COOP stock 5 years ago, it would be worth $1,160.09 today based on a price of $156.38 for COOP at the time of writing.
<h3>Mr. Cooper Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753393524_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

COOP

Here's How Much You Would Have Made Owning Mr. Cooper Gr Stock In The Last 5 Years

Scholastic Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCHL#NASDAQ">SCHL</a>) shares are climbing after the company released its second-quarter results after Thursday's closing bell. Here's a look at the key figures <a href="https://www.benzinga.com/pressreleases/25/07/n46616156/scholastic-reports-fourth-quarter-and-fiscal-2025-results">from the quarter.&nbsp;&nbsp;</a>
Check out the current price of <a href="https://www.benzinga.com/quote/SCHL">SCHL stock here</a>.
The Details:&nbsp;Scholastic&nbsp;reported quarterly adjusted earnings of 87 cents per share, which beat the 85 cent analyst consensus estimate. Quarterly revenue came in at $508.3 million, beating the&nbsp;$494.58 million Street estimate.
Read Next:&nbsp; <a href="https://www.benzinga.com/markets/tech/25/07/46505139/quantum-stock-tracker-rigetti-achieves-major-breakthrough-but-jim-cramer-names-another-stock-to-own?utm_source=articleShare">Quantum Stock Tracker: Rigetti Achieves Major Breakthrough, But Jim Cramer Names Another Stock To &#8216;Own&#8217;</a>
&#8220;Scholastic delivered solid financial results in fiscal 2025, with strong Adjusted EBITDA in line with our original guidance,&#8221; CEO Peter Warwick said. 
&#8220;In the fourth quarter, continued strength in Children&#8217;s Book Publishing and Distribution, combined with successful execution and disciplined cost management, helped offset macroeconomic pressures on school spending, which continued to impact the Education division,&#8221; Warwick added. 
Outlook:&nbsp;Scholastic said it expects &#8220;significant growth&#8221; in fiscal 2026 Adjusted EBITDA to&nbsp;$160 million&nbsp;to&nbsp;$170 million, reflecting strength in its core businesses and cost savings, partly offset by continued headwinds on school spending.
Revenue is expected to grow 2% to 4% in fiscal 2026.&nbsp;
SCHL Price Action: According to data from<a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw"> Benzinga Pro</a>, Scholastic stock was up 12.39% at $24.22 in Thursday's extended trading.&nbsp;
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/space/25/07/46534529/space-stock-tracker-virgin-galactic-makes-a-comeback-while-rocket-lab-takes-a-breather?utm_source=articleShare">Space Stock Tracker: Virgin Galactic Makes A Comeback While Rocket Lab Takes A Breather</a></li>
</ul>
Photo: Shutterstock

Education

After-Hours Center

Movers

SCHL

Scholastic Stock Soars After Q4 Results Are At Head Of The Class

Hammond Power Solns (TSX:<a class="ticker" href="https://www.benzinga.com/stock/HPS#TSX">HPS</a>) reported quarterly earnings of $1.72 per share which beat the analyst consensus estimate of $1.70 by 1.18 percent. This is a 13.13 percent decrease over earnings of $1.98 per share from the same period last year. The company reported quarterly sales of $224.419 million which beat the analyst consensus estimate of $215.567 million by 4.11 percent. This is a 13.80 percent increase over sales of $197.212 million the same period last year.

TSX:HPS

TSX:HPS.A

Hammond Power Solns Q2 Adj. EPS $1.72 Beats $1.70 Estimate, Sales $224.419M Beat $215.567M Estimate

Guidance

INTC

During Conference Call, Intel Exec Says Anticipate 2025 Gross Capital Investment Will Be ~$18B

Pinetree Cap (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PNP#TSX">PNP</a>) reported quarterly losses of $(0.18) per share. This is a 80 percent decrease over losses of $(0.10) per share from the same period last year. The company reported $(913.000 thousand) in sales this quarter. This is a 13.14 percent decrease over sales of $(807.000 thousand) the same period last year.

TSX:PNP

Pinetree Cap Q2 GAAP EPS $(0.18) Down From $(0.10) YoY, Sales $(913.000K) Down From $(807.000K) YoY

During Conference Call, Intel CFO Says Expect Intel Foundry Revenue Sequentially Down Slightly In Q3 Due To Capacity Constraints In Intel 7

Bank of New York Mellon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) has outperformed the market over the past 5 years by 8.03% on an annualized basis producing an average annual return of 22.62%. Currently, Bank of New York Mellon has a market capitalization of $70.50 billion. 
Buying $100 In BK: If an investor had bought $100 of BK stock 5 years ago, it would be worth $279.64 today based on a price of $99.97 for BK at the time of writing.
<h3>Bank of New York Mellon's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753392624_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Bank of New York Mellon Stock In The Last 5 Years

Boston Beer Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) reported second-quarter financial results Thursday after the bell. Here&#8217;s a rundown of <a href="https://www.benzinga.com/pressreleases/25/07/g46616885/boston-beer-reports-second-quarter-financial-results">the company&#8217;s report</a>.
Check out the current price of <a href="https://www.benzinga.com/quote/SAM">SAM stock here.</a>
Q2 Earnings: Boston Beer reported second-quarter revenue of $587.95 million, missing analyst&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $596.43 million. The craft brewer reported second-quarter earnings of $5.45 per share, beating estimates of $4.04 per share, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Total revenue for the second quarter was up 1.5% due to increased pricing and favorable product mix, partially offset by lower volumes. Shipment volume was down 0.8% year-over-year to approximately 2.1 million barrels. Boston Beer saw shipment declines in Truly Hard Seltzer and Samuel Adams brands during the period.
The company ended the quarter with $212.43 million in cash and cash equivalents. 
&#8220;Our depletions declined by&nbsp;5%&nbsp;in the&nbsp;second quarter&nbsp;as volumes were pressured across the beer industry due to economic uncertainty impacting consumer behavior and some impact from poor weather in some key selling weeks,&#8221; said Jim Koch, founder and chairman of Boston Beer. &#8220;While the external environment remains dynamic, we were able to grow share in the first half of this year.&#8221;
Guidance: Boston Beer affirmed its full-year 2025 earnings guidance of $8 to $10.50 per share versus estimates of $9.13 per share. The company also raised its gross margin guidance due to better-than-expected brewery efficiencies in the first half of the year.
SAM Price Action: <a href="http://benzinga.com/quote/SAM">Boston Beer shares</a> were up 7.67% in after-hours, trading at $217,28 at the time of publication on Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/07/46617338/hoka-ugg-parent-deckers-outdoor-stock-rallies-15-after-q1-report-heres-why">HOKA, UGG Parent Deckers Outdoor Stock Rallies 15% After Q1 Report: Here&#8217;s Why</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/scukrov">Steve Cukrov</a>/Shutterstock.com

Restaurants

Boston Beer Q2 Earnings: Revenue Miss, EPS Beat; Truly, Sam Adams Shipments Decline, But Overall Market Share Grows

Ovintiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OVV#NYSE">OVV</a>) reported quarterly earnings of $1.02 per share which beat the analyst consensus estimate of $0.97 by 5.37 percent. This is a 17.07 percent decrease over earnings of $1.23 per share from the same period last year. The company reported quarterly sales of $2.318 billion which beat the analyst consensus estimate of $1.911 billion by 21.30 percent. This is a 1.31 percent increase over sales of $2.288 billion the same period last year.

CORRECTION: Ovintiv Q2 Adj. EPS $1.02 Beats $0.97 Estimate, Sales $2.318B Beat $1.911B Estimate

<a href="https://x.com/secscottbessent/status/1948493917940257199?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg">https://x.com/secscottbessent/status/1948493917940257199?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg</a>

Macro Notification

Economics

U.S. Treasury's Bessent Posts On X "Today, I met with Deputy Prime Minister and Minister for Trade and Industry Gan Kim Yong of Singapore.I was pleased to hear the Deputy Prime Minister's views on the economic relationship between the United States and Singapore and I look forward to our continued cooperation on our shared priorities"

Macro Economic Events

Politics

Global

Reuters Cites Brazil's VP Alckmin Saying We Spoke On Saturday With The U.S.' Commerce Secretary; I Spoke With Lutnick, Reiterated Brazil's Willingness To Negotiate Tariffs; Conversation With Lutnick Was Good, But It Was Private

Winpak (TSX:<a class="ticker" href="https://www.benzinga.com/stock/WPK#TSX">WPK</a>) reported quarterly earnings of $0.49 per share which missed the analyst consensus estimate of $0.62 by 20.97 percent. This is a 19.67 percent decrease over earnings of $0.61 per share from the same period last year. The company reported quarterly sales of $272.800 million which missed the analyst consensus estimate of $289.982 million by 5.93 percent. This is a 3.77 percent decrease over sales of $283.496 million the same period last year.

Earnings Misses

TSX:WPK

Winpak Q2 GAAP EPS $0.49 Misses $0.62 Estimate, Sales $272.800M Miss $289.982M Estimate

During Conference Call, Intel CEO Says Intel 18a Manufacturing Technology Could Generate A Reasonable Return On Investments With Only Internal Intel Products; Increase In Capital Costs At Intel 14a Make It Clear That Need Both Intel Products And A Meaningful External Customer To Drive "Acceptable Returns" On Deploy Capital; Will Review And Approve Every Major Intel Chip Design; Last Full Fiscal Year Of Positive Adjust Free Cash Flow Was 2021

Comments

Humble Gr

Notizie

Ultime notizie per Humble Gr (OTC:HMBAF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO